Staff support for back surgical patients and family members: does it improve coping at home?

Orthop Nurs

Päivi Leikkola, MSc (Health), Nursing Director, University of Tampere, School of Health Sciences, Tampere, Finland, and Hospital District of South Ostrobothnia, Seinäjoki, Finland. Mika Helminen, MSc, Biostatistician, University of Tampere, School of Health Sciences, Tampere, Finland, and Hospital District of Pirkanmaa, Department of Research Administration, Tampere, Finland. Eija Paavilainen, PhD, Professor, University of Tampere, School of Health Sciences, Tampere, Finland, and Hospital District of South Ostrobothnia, Seinäjoki, Finland. Päivi Åstedt-Kurki, PhD, Professor, University of Tampere, School of Health Sciences, Tampere, Finland, and Hospital District of Pirkanmaa, Department of Research Administration, Tampere, Finland.

Published: September 2016

Background: social support is an important form of external support to patients and families.

Purpose: Assessment of postoperative external support provided by staff to patients and family members at discharge from hospital and related factors.

Methods: Quantitative descriptive study conducted with surgical patients treated for disc herniation or spinal stenosis (N = 92) and family members (N = 55) in a central hospital in Finland in 2008-2010 to measure the importance of various forms of support and their association with respondents' overall postoperative coping.

Results: Patient education atmosphere was the most important source of external support for both patients and family members. Better overall coping was reported by both groups if the patient's behavior and intrafamilial emotions had changed in a positive way. Patients' overall coping was promoted if they received adequate information from staff.

Conclusions: Nurses' role and competence are crucial in supporting the coping of patients and families.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NOR.0000000000000099DOI Listing

Publication Analysis

Top Keywords

family members
16
patients family
12
external support
12
surgical patients
8
support patients
8
patients
6
support
5
staff support
4
support surgical
4
family
4

Similar Publications

Aim: Sarcopenic obesity (SO) is associated with adverse outcomes in diseased patients. This study aimed to examine the prevalence and risks associated with SO, with a focus on the impact of SO on cardiovascular risk in patients with MASLD.

Materials And Methods: In this cross-sectional study, patients with MASLD were prospectively enrolled.

View Article and Find Full Text PDF

Modulation of Intestinal Inflammation and Protection of Dopaminergic Neurons in Parkinson's Disease Mice through a Probiotic Formulation Targeting NLRP3 Inflammasome.

J Neuroimmune Pharmacol

January 2025

Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, PR China.

Emerging evidence highlights the significance of peripheral inflammation in the pathogenesis of Parkinson's disease (PD) and suggests the gut as a viable therapeutic target. This study aimed to explore the neuroprotective effects of the probiotic formulation VSL#3 and its underlying mechanism in a PD mouse model induced by MPTP. Following MPTP administration, the striatal levels of dopamine and its metabolites, as along with the survival rate of dopaminergic neurons in the substantia nigra, were significantly reduced in PD mice.

View Article and Find Full Text PDF

Purpose Of Review: Addressing diabetes distress (DD), the emotional demands of living with diabetes, is a crucial component of diabetes care. Most individuals with type 2 diabetes and approximately half of adults with type 1 diabetes receive their care in the primary care setting. This review will provide guidance on addressing DD and implementing targeted techniques that can be tailored to primary care patients.

View Article and Find Full Text PDF

Background: Celiac disease (CeD) has shown an association with autoimmune disorders including vitiligo and alopecia areata (AA). Ritlecitinib, a JAK3 and TEC kinase family inhibitor, has been approved for treatment of patients with AA and is in late-stage development for vitiligo. Ritlecitinib inhibits cytotoxic T cells, NK cells, and B cells which play a role in the pathogenesis of CeD.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by systemic inflammation. While RA primarily affects the joints, its systemic effects may lead to an increased cerebro- and cardiovascular risk. Atherosclerosis of the carotid arteries is a significant risk factor for cerebrovascular events and serves as a surrogate marker for cardiovascular risk.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!